3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Glabellar Lines: new trials by email Literature Review of Glabellar Lines trials Research Report on Glabellar Lines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines Dysport reconstituted at 1.5 mL (0.05 mL/injection), Dysport reconstituted at 2.5 mL (0.08 mL/injection) - Glabellar Lines, Wrinkles | Phase 4 | Completed | Galderma R&D | 60 | 2016-04-01 | 2022-08-01 |
| Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study) onabotulinumtoxinA, bimatoprost ophthalmic solution 0.03%, JUVÉDERM® ULTRA XC - Facial Rhytides, Crow's Feet Lines | Phase 4 | Completed | Allergan | 116 | 2014-06-30 | 2019-01-09 |
| Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines botulinum toxin type A - Glabellar Lines | Phase 4 | Completed | Allergan | 224 | 2010-09-01 | 2019-01-29 |
Botulinum Toxins, Type A (2) · Bimatoprost (1) · Injections (1) · incobotulinumtoxinA (1)
Allergan (2) · Galderma R&D (1)
United States (2) · Germany (1)